Found 21 results
Filters: Author is Nair, Viji  [Clear All Filters]
2018
Nair V, Komorowsky CV, E Weil J, Yee B, Hodgin J, Harder JL, Godfrey B, Ju W, Boustany-Kari CM, Schwarz M et al..  2018.  A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome.. Kidney Int. 93(2):439-449.
2017
Nishizono R, Kikuchi M, Wang SQ, Chowdhury M, Nair V, Hartman J, Fukuda A, Wickman L, Hodgin JB, Bitzer M et al..  2017.  FSGS as an Adaptive Response to Growth-Induced Podocyte Stress.. J Am Soc Nephrol. 28(10):2931-2945.
Nair V, Robinson-Cohen C, Smith MR, Bellovich KA, Bhat ZYousuf, Bobadilla M, Brosius F, de Boer IH, Essioux L, Formentini I et al..  2017.  Growth Differentiation Factor-15 and Risk of CKD Progression.. J Am Soc Nephrol. 28(7):2233-2240.
Zhang H, Nair V, Saha J, Atkins KB, Hodgin JB, Saunders TL, Myers MG, Werner T, Kretzler M, Brosius FC.  2017.  Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice.. Kidney Int. 92(4):909-921.
Liu P, Lassén E, Nair V, Berthier CC, Suguro M, Sihlbom C, Kretzler M, Betsholtz C, Haraldsson B, Ju W et al..  2017.  Transcriptomic and Proteomic Profiling Provides Insight into Mesangial Cell Function in IgA Nephropathy.. J Am Soc Nephrol. 28(10):2961-2972.
2016
Sampson MG, Robertson CC, Martini S, Mariani LH, Lemley KV, Gillies CE, Otto EA, Kopp JB, Randolph A, Vega-Warner V et al..  2016.  Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.. J Am Soc Nephrol. 27(3):814-23.
Sas KM, Kayampilly P, Byun J, Nair V, Hinder LM, Hur J, Zhang H, Lin C, Qi NR, Michailidis G et al..  2016.  Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications.. JCI Insight. 1(15):e86976.
Hur J, O'Brien PD, Nair V, Hinder LM, McGregor BA, Jagadish HV, Kretzler M, Brosius FC, Feldman EL.  2016.  Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns.. Diabetologia. 59(6):1297-306.
2015
Iyengar SK, Sedor JR, Freedman BI, Kao WHLinda, Kretzler M, Keller BJ, Abboud HE, Adler SG, Best LG, Bowden DW et al..  2015.  Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).. PLoS Genet. 11(8):e1005352.
Lai JY, Luo J, O'Connor C, Jing X, Nair V, Ju W, Randolph A, Ben-Dov IZ, Matar RN, Briskin D et al..  2015.  MicroRNA-21 in glomerular injury.. J Am Soc Nephrol. 26(4):805-16.
Sas KM, Nair V, Byun J, Kayampilly P, Zhang H, Saha J, Brosius FC, Kretzler M, Pennathur S.  2015.  Targeted Lipidomic and Transcriptomic Analysis Identifies Dysregulated Renal Ceramide Metabolism in a Mouse Model of Diabetic Kidney Disease.. J Proteomics Bioinform. Suppl 14
Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PXK, Mariani LH, Eichinger FH, Berthier CC, Randolph A et al..  2015.  Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.. Sci Transl Med. 7(316):316ra193.
2014
Martini S, Nair V, Keller BJ, Eichinger F, Hawkins JJ, Randolph A, Böger CA, Gadegbeku CA, Fox CS, Cohen CD et al..  2014.  Integrative biology identifies shared transcriptional networks in CKD.. J Am Soc Nephrol. 25(11):2559-72.
Dessapt-Baradez C, Woolf AS, White KE, Pan J, Huang JL, Hayward AA, Price KL, Kolatsi-Joannou M, Locatelli M, Diennet M et al..  2014.  Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.. J Am Soc Nephrol. 25(1):33-42.
2013
Merscher-Gomez S, Guzman J, Pedigo CE, Lehto M, Aguillon-Prada R, Mendez A, Lassenius MI, Forsblom C, Yoo T, Villarreal R et al..  2013.  Cyclodextrin protects podocytes in diabetic kidney disease.. Diabetes. 62(11):3817-27.
Ju W, Greene CS, Eichinger F, Nair V, Hodgin JB, Bitzer M, Lee Y-S, Zhu Q, Kehata M, Li M et al..  2013.  Defining cell-type specificity at the transcriptional level in human disease.. Genome Res. 23(11):1862-73.
Sanchez-Niño MDolores, Poveda J, Sanz ABelen, Mezzano S, Carrasco S, Fernandez-Fernandez B, Burkly LC, Nair V, Kretzler M, Hodgin JB et al..  2013.  Fn14 in podocytes and proteinuric kidney disease.. Biochim Biophys Acta. 1832(12):2232-43.
Martini S, Nair V, Patel SR, Eichinger F, Nelson RG, E Weil J, Pezzolesi MG, Krolewski AS, Randolph A, Keller BJ et al..  2013.  From single nucleotide polymorphism to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy.. Diabetes. 62(7):2605-12.
Hodgin JB, Nair V, Zhang H, Randolph A, Harris RC, Nelson RG, E Weil J, Cavalcoli JD, Patel JM, Brosius FC et al..  2013.  Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.. Diabetes. 62(1):299-308.
2012
Berthier CC, Bethunaickan R, Gonzalez-Rivera T, Nair V, Ramanujam M, Zhang W, Böttinger EP, Segerer S, Lindenmeyer M, Cohen CD et al..  2012.  Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis.. J Immunol. 189(2):988-1001.
El-Meanawy A, Schelling JR, Iyengar SK, Hayden P, Barathan S, Goddard K, Pozuelo F, Elashi E, Nair V, Kretzler M et al..  2012.  Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes.. BMC Nephrol. 13:61.